TL Private Wealth’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

TL Private Wealth’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,000	Closed	-$108K	–	51
2021 Q3	$108K	Buy	+16,000	New	+$136K	0.06%	49
2021 Q2	–	Sell	-16,000	Closed	-$111K	–	50
2021 Q1	$111K	Buy	+16,000	New	+$169K	0.07%	50

Other funds holding SRNE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TL Private Wealth's SRNE Position: Q4 2021 in Review

TL Private Wealth sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 16,000 shares — an estimated $108K sold.

TL Private Wealth first reported a position in SRNE in Q1 2021 and held it in 2 quarters. The position peaked at $111K in Q1 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

TL Private Wealth reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
TL Private Wealth sold 16,000 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $108K.
TL Private Wealth first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 2 quarters.
TL Private Wealth's Sorrento Therapeutics, Inc. position peaked at $111K in Q1 2021.
234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on TL Private Wealth's 13F filing for Q4 2021, filed 26 Jan 2022.